Intragastric balloons market seen reaching $36.1 billion by 2030

The intragastric balloons market is projected to climb from $24.55 billion in 2026 to $36.1 billion by 2030 as demand grows for non-surgical obesity treatments. North America leads the market now, while Asia-Pacific is expected to grow fastest as obesity rates rise and endoscopic access expands.

Why it matters: - The intragastric balloons market is expanding because obesity is rising worldwide and more patients want minimally invasive weight-loss options. - The market's growth points to broader demand for reversible, non-surgical obesity treatments that avoid traditional bariatric surgery.

What happened: - The Business Research Company projected the intragastric balloons market will increase from $22.05 billion in 2025 to $24.55 billion in 2026. - The same forecast puts the market at $36.1 billion by 2030. - The company said the market is being shaped by demand for non-surgical obesity treatment, higher obesity-related health complications, preventive weight management and wider access to endoscopic bariatric procedures.

The details: - Intragastric balloons are minimally invasive devices placed inside the stomach to temporarily reduce stomach capacity. - The procedure does not require general anesthesia. - The balloons create a feeling of fullness by taking up space in the stomach, which helps limit food intake. - Placement typically happens through an endoscope passed through the mouth into the stomach. - The market grew in recent years because of rising obesity rates, more awareness of weight-management options, the limits of lifestyle changes alone and broader availability of bariatric and endoscopic services. - The report identified growing use of non-surgical weight-loss methods, temporary bariatric options, pre-surgical weight reduction and comprehensive obesity management programs as major trends. - The report also highlighted stronger acceptance of endoscopic interventions. - Obesity is generally defined as a body mass index of 30 or above. - The World Obesity Federation's World Obesity Atlas 2022 estimated that if current prevention and treatment strategies do not change, the global economic burden of overweight and obesity could reach $4.32 trillion annually by 2035. - The same report estimated more than 4 billion people could be overweight or obese by 2035, including nearly 2 billion people with obesity. - The report includes a free sample download and a full market report available through The Business Research Company's website. - The full report is available here. - A free sample is available here.

Between the lines: - The forecast suggests intragastric balloons are moving from a niche procedure toward a more established part of obesity care. - The market outlook also reflects a shift away from one-time surgical intervention and toward repeatable, reversible treatment pathways. - North America held the largest market share in 2025, which fits its stronger healthcare infrastructure and higher adoption rates. - Asia-Pacific is expected to grow fastest as awareness rises, obesity increases and medical services expand.

What's next: - The report expects continued growth as more patients seek non-surgical weight-loss solutions and healthcare systems expand endoscopic bariatric offerings. - The market analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, key technologies analysis and updated graphics and tables.